Clinical Trial Update: A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study to evaluate skin irritation and sensitization of the selegiline transdermal system in healthy subjects; Major depressive disorder is listed as a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Selegiline transdermal system (selegiline)

Snippet

Sponsor: Corium Innovations, Inc. | Conditions: Major Depressive Disorder (MDD) | Phase 1 | Status: NOT_YET_RECRUITING